ACCREDITATION EXPIRED - Program content available for information only. Join Dr. Jim Neuenschwander as he hosts Dr. Michael Broyles and Dr. Eric Gluck in an informative discussion of the role of procalcitonin biomarker testing to help direct anti-infective therapy in the face of COVID-19 infections. The need to continue to rapidly assess patients and initiate the most appropriate therapy, whether antiviral or antimicrobial is even more critical as the continue to be severe issues of overcrowding in hospital Emergency Departments and Critical Care Units.

This accredited enduring video activity provides practitioners with practical guidance on the utilization of PCT in the management of suspected bacterial infections and its improvement on antimicrobial stewardship.  Appropriate utilization of PCT biomarker assays have proven to be of value in reducing unnecessary antimicrobial therapy.